The drug is withdrawn because it cannot meet the quality requirement on the criterion of lipopolysaccharide in the solvent.
The Drug Administration of Vietnam requested that Vinphaco cooperates with its distributors to send notice to all wholesalers, retailers, and users nationwide of the mentioned drug about the withdrawal.
The batch of below-standard injection must be immediately taken back, and proper reports on the task as well as proofs of this activity must be prepared.
The Departments of Health in Hanoi and Vinh Phuc Province are asked to monitor Vinphaco when carrying out this task in accordance with related regulations.
Other departments of Health in provinces and cities also need to issue notice to all pharmaceutical businesses and users about the drug withdrawal.
Vintrypsine injection is normally used to reduce inflammation of soft tissue due to abscess or injuries. It is also used to decrease respiratory secretions for patients of asthma, bronchitis, sinusitis, and other respiratory diseases.
